tbuckley/cabot-search huggingface dataset:
Presacral Myelolipoma
Authors: Laurent Guillaume, Thierry Vander Borght, Claude Bertrand, Michael Dupont, Bruno Krug
Journal: Clinical Nuclear Medicine (2020)

Abstract Myelolipoma is a rare mesenchymal tumor consisting of adipose tissue and hematopoietic cells. Found usually in the adrenal region, however, few cases have been reported in extra-adrenal regions, most frequently in the presacral region. It is important to recognize such tumor, as it can attain massive size and causes pressure symptoms, and needs to be differentiated from malignant tumors, including liposarcomas. Although CT and MRI can suggest a diagnosis of myelolipoma, these are not conclusive. The hematopoietic cells are enhanced by a 99m Tc–albumin nanocolloid scintigraphy and help to distinguish myolipoma from other entities.
Clinical Outcomes Following Treatment with Gilteritinib or Quizartinib in Patients with Relapsed/Refractory <i>FLT3</i>-ITD+ Acute Myeloid Leukemia
Authors: Alexander E. Perl, Qiaoyang Lu, Alan Fan, Nahla Hasabou, Erhan Berrak, Ramon V. Tiu
Journal: Blood (2020)
Intraoperative Dexamethasone During Pediatric Cardiac Surgery
Authors: Yang Wang, Tao Chen, Wei Li
Journal: JAMA (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Clonal Hematopoiesis with Somatic Mutations in "AYA" Generation of Patients with Chronic Myeloid Leukemia
Authors: Jitka Koblihova, Vaclava Polivkova, Adela Benesova, Hana Zizkova, Nikola Curik, Monika Pepek, Tomasz Stoklosa, Marketa Markova Stastna, Hana Klamová, Dana Srbova, Katerina Machova
Journal: Blood (2020)
Development and Validation of a Computable Phenotype for Bleeding in Hospitalized Patients: The Medical Inpatients Thrombosis and Hemostasis (MITH) Study
Authors: Mansour Gergi, Katherine Wilkinson, Insu Koh, Jordan Munger, Nicholas L Smith, Nicholas Roetker, Mary Cushman, Allen B Repp, Chris E. Holmes, Zakai A Neil
Journal: Blood (2020)
Abstract 304: Adaptive Sarcomeric Remodeling of Left Atrial Cardiomyocytes in Non-failing Non-valvular Atrial Fibrillation
Authors: Parth V Desai, Thomas Martin, Marisa Stachowski, Maria Papadaki, Jonathan A Kirk
Journal: Circulation Research (2020)

Contractile remodeling in sustained atrial fibrillation (AF) has been analyzed by limited studies whose results were confounded by either coexisting systolic heart failure or valve disease (valvular AF) or origin of tissue (right chamber instead of left, atrial appendage instead of main wall). We sought to assess the structural changes in contractile apparatus and its physiological implications on single cardiomyocyte mechanics in patients with non-failing non-valvular AF. We utilized left atrial wall tissue from rejected donor hearts from 5 subjects in sinus rhythm (SR) and 3 with AF (age 50, 2♀ vs 60, 1♀), all with no signs of cardiovascular or valvular disease. Isolated single skinned myocytes were mounted to a force transducer and length controller and set to an initial sarcomere length of 2.1 μm. Isometric active and passive forces were recorded using custom software during [Ca2+] solution switching (0.79 - 46.8 μM). Surprisingly, we found that isometric maximal calcium-activated force (Fmax) was almost two times higher in AF compared to SR patients (n: SR = 15 cells, AF = 9 cells, p &lt; 0.0001). This was unexpected, as previous studies found that AF patients had depressed contractile function, although these were confounded by heart failure and valve disease. There were no differences in calcium sensitivity, hill coefficient, or cell cross-sectional area (CSA) between SR and AF. We next performed 1D SDS-PAGE electrophoresis to compare myosin heavy chain (MHC) isoforms. In SR patients, atrial expression of β-MHC was very low (14% of total MHC expression), but this was significantly elevated in AF patients (37%, p = 0.05). The observed rise in contractile force might be a compensatory adaptation to sustain ventricular filling in initial stages of non-valvular non-failing AF patients. Or it may be a maladaptive response to atrial unloading resulting in wasted energy utilization. The contribution of this cellular increase in contractility to whole organ function is unclear. There is strong evidence that fibrotic remodeling and inflammation play an important role in AF, but the clinical challenge is still significant. Conversely, there has been very little work done on the contractile apparatus in AF, and whether it may represent a possible therapeutic target.
Diagnosis of Neuropathy and Risk Factors for Corneal Nerve Loss in Type 1 and Type 2 Diabetes: A Corneal Confocal Microscopy Study
Authors: Maryam Ferdousi, Alise Kalteniece, Shazli Azmi, Ioannis N. Petropoulos, Georgios Ponirakis, Uazman Alam, Omar Asghar, Andrew Marshall, Catherine Fullwood, Maria Jeziorska, Caroline Abbott, Giuseppe Lauria, Catharina G. Faber, Handrean Soran, Nathan Efron, Andrew J.M. Boulton, Rayaz A. Malik
Journal: Diabetes Care (2020)

OBJECTIVE To assess the diagnostic utility of corneal confocal microscopy (CCM) for diabetic peripheral neuropathy (DPN) and the risk factors for corneal nerve loss. RESEARCH DESIGN AND METHODS A total of 490 participants, including 72 healthy control subjects, 149 with type 1 diabetes, and 269 with type 2 diabetes, underwent detailed assessment of peripheral neuropathy and CCM in relation to risk factors. RESULTS Corneal nerve fiber density (CNFD) (P &amp;lt; 0.0001 and P &amp;lt; 0.0001), corneal nerve fiber branch density (CNBD) (P &amp;lt; 0.0001 and P &amp;lt; 0.0001), and corneal nerve fiber length (CNFL) (P &amp;lt; 0.0001 and P = 0.02) were significantly lower in patients with type 1 and type 2 diabetes compared with control subjects. CNFD (P &amp;lt; 0.0001), CNBD (P &amp;lt; 0.0001), and CNFL (P &amp;lt; 0.0001) were lower in type 1 diabetes compared with type 2 diabetes. Receiver operating characteristic curve analysis for the diagnosis of DPN demonstrated a good area under the curve for CNFD of 0.81, CNBD of 0.74, and CNFL of 0.73. Multivariable regression analysis showed a significant association among reduced CNFL with age (β = −0.27, P = 0.007), HbA1c (β = −1.1; P = 0.01), and weight (β = −0.14; P = 0.03) in patients with type 2 diabetes and with duration of diabetes (β = −0.13; P = 0.02), LDL cholesterol (β = 1.8, P = 0.04), and triglycerides (β = −2.87; P = 0.009) in patients with type 1 diabetes. CONCLUSIONS CCM identifies more severe corneal nerve loss in patients with type 1 diabetes compared with type 2 diabetes and shows good diagnostic accuracy for DPN. Furthermore, the risk factors for a reduction in corneal nerve fiber length differ between type 1 and type 2 diabetes.
A remarkable case of HbH disease illustrates the relative contributions of the α-globin enhancers to gene expression
Authors: Mohsin Badat, James O. J. Davies, Christopher A. Fisher, Damien J. Downes, Anna Rose, Andreas B. Glenthøj, Eduard J. van Beers, Cornelis L. Harteveld, Douglas R. Higgs
Journal: Blood (2020)
Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell Therapies
Authors: Mark B. Leick, Marcela V. Maus, Matthew J. Frigault
Journal: Molecular Therapy (2020)

Large B cell lymphoma (LBCL) is curable with standard chemo-immunotherapy in the majority of cases. However, patients with primary refractory or relapsed disease have historically had limited treatment options. Two gene-modified chimeric antigen receptor (CAR)-T cell therapies have now been approved for these indications. The clinical decisions and management surrounding these gene-modified "living drugs" are nuanced and complex. In this article, we discuss the evolving evidence supporting the use of these CAR-T cells, including patient selection, screening procedures, special populations, bridging therapy, lymphodepletion, clinical management, relapse, and follow up. Large B cell lymphoma (LBCL) is curable with standard chemo-immunotherapy in the majority of cases. However, patients with primary refractory or relapsed disease have historically had limited treatment options. Two gene-modified chimeric antigen receptor (CAR)-T cell therapies have now been approved for these indications. The clinical decisions and management surrounding these gene-modified "living drugs" are nuanced and complex. In this article, we discuss the evolving evidence supporting the use of these CAR-T cells, including patient selection, screening procedures, special populations, bridging therapy, lymphodepletion, clinical management, relapse, and follow up.
Pediatric Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab
Authors: Ignacio Oulego-Erroz, Jorge Martínez-Sáenz de Jubera, Carlos Ocaña-Alcober, Laura Regueras-Santos, Luis Ferrero-De la Mano, Juan Pablo Martínez-Badás
Journal: American Journal of Respiratory and Critical Care Medicine (2020)
New Perspectives and Challenges Regarding Fertility, Conception and Pregnancy in Hemoglobinopathies. a Multidisciplinary Report of 66 Outcomes
Authors: Lorenza Torti, Laura Maffei, Francesco Sorrentino, Paolo De Fabritiis, Donatella Dell'Anna, Maurizio Poggi, Stefano Aureli, Giovanni Loyola, Rocco Rago, Elisabetta Abruzzese
Journal: Blood (2020)
AB0051 Age-related peculiarities in the course of rheumatoid arthritis
Authors: NA Artemenko, LP Sizyakina
Journal: Annals of the Rheumatic Diseases (2001)

<h3>Background</h3> <h3>Objectives</h3> <h3>Methods</h3> We examined 70 patients diagnosed for rheumatoid arthritis (RA) represented by three age groups: from 20 to 40 years (24 persons), from 40 to 60 years (36 persons), and over 60 years (10 persons). <h3>Results</h3> In the majority of the patients we found the 2nd degree of the disease activity (51 persons), and the 2<sup>nd </sup>radiological stage of RA (45 persons). We analysed the changes in the immunological status, the concentration of the antibodies to phospholipids, the IgM rheumatoid factor, the antibodies reacting with the native DNA, and the von Willebrand factor. We found that RA in the lowest-age group was accompanied by the most marked changes in the immunological values, which was indicative of high autoimmune aggressiveness. The course of the disease in the middle age group was characterised by the least significant disruption of the cell and humoral immune reactions. <h3>Conclusion</h3> It can be said that the main feature of the course of RA in the highest age group patients is the development of extra-articular manifestations, that significantly worsen the quality and reduce the duration of life.
Randomized Controlled Trial of Fixed Low-Vs Moderate-Dose Hydroxyurea for Primary Stroke Prevention in Sub-Saharan Africa: Final Results of the Spring Trial
Authors: Shehu Umar Abdullahi, Binta W. Jibir, Halima Bello-Manga, Safiya Gambo, Hauwa Inuwa, Aliyu Gaya Tijjani, Aisha Amal Galadanci, Awwal Musa Borodo, Najibah Aliyu Galadanci, Nura Idris, Abulkadir M Tabari, Lawal Haliru, Khadija Bulama, Gloria Bahago, Mohammed A. Sani, Aisha Suleiman, Murtala Umar, Charity Dooshima, Aisha Kazaure, Bilya Sani Musa, Fahad M Usman, Abdulrasheed Sani, Awwal Gambo, Jamila S. Ibrahim, Mustapha Hikima, Aisha B. Musa, Abdu H. Dambatta, Jamil Aliyu Galadanci, Brittany Covert Greene, Djamila Labib Ghafuri, Mark Rodeghier, James Slaughter, Fenella Jane Kirkham, Kathleen Neville, Adetola A. Kassim, Muktar Aliyu, Lori C. Jordan, Edwin Trevathan, Michael R. DeBaun
Journal: Blood (2020)
Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers; The Prospective Nordic Study NMDSG14B
Authors: Magnus Tobiasson, Tatjana Pandzic, Johanna Illman, Lars Nilsson, Simone Weström, Daniel Olsson, Elisabeth Ejerblad, Astrid Olsnes Kittang, Gitte Olesen, Olle Werlenius, Andreas T Björklund, Fryderyk Lorentz, Bengt Erik Holger Rasmussen, Jörg Cammenga, Duruta Weber, Marios Dimitriou, Soili Kytölä, Gunilla Walldin, Kirsten Groenbaek, Stephan Mielke, Sten Eirik Waelgaard Jacobsen, Freja Ebeling, Lucia Cavelier, Lone Smidstrup Friis, Ingunn Dybedal, Eva Hellstrom Lindberg
Journal: Blood (2020)
Population Pharmacokinetics and Exposure-Response Analyses for Glofitamab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R NHL): Confirmation of Efficacy and CRS Mitigation in Patients with Step-up Dosing
Authors: Nassim Djebli, Peter N Morcos, Félix Jaminion, Elena Guerini, Nicole A Kratochwil, Nicole Justies, Eginhard Schick, Antonia Kwan, Kathryn Humphrey, Linda Lundberg, David Carlile
Journal: Blood (2020)
<i>IDH</i> Mutations Are Associated with an Increased Risk of Coronary Artery Disease and Cardiotoxicity in Patients with Established AML
Authors: Badder Kattih, Amir Shirvani, Piroska Klement, Abel Martin Garrido, Razif Gabdoulline, Alessandro Liebich, Maximilian Brandes, Anuhar Chaturvedi, Timon Seeger, Felicitas Thol, Gudrun Gohring, Brigitte Schlegelberger, Robert Geffers, David John, Udo Bavendiek, Johann Bauersachs, Arnold Ganser, Joerg Heineke, Michael Heuser
Journal: Blood (2020)
Abstract 11977: MediYoga Improves Health Related Quality of Life and Blood Pressure Among Patients With Paroxysmal Atrial Fibrillation - The MYPAF Study
Authors: Maria Wahlström, Mårten Rosenqvist, Jörgen Medin, Monica Rydell Karlsson
Journal: Circulation (2018)

Introduction: There is substantial evidence of impaired health related quality of life (HRQoL) in patients with paroxysmal atrial fibrillation (PAF). Few studies have evaluated self-management prog...
Solitary 68Ga-PSMA–Avid Proximal Tibial Prostatic Adenocarcinoma Metastasis Mimicking Enthesopathy
Authors: Luke Hilliar, Joshua Wei Liang Yip, Ken Le, Han Loh, Robert Mansberg
Journal: Clinical Nuclear Medicine (2020)

A 76-year-old man with previously treated prostatic adenocarcinoma (Gleason 8) was referred for a Ga-prostate-specific membrane antigen PET/CT scan due to a rising serum PSA level. An intensely PSMA-avid focus was demonstrated in the left proximal tibia with no evidence of local recurrence or metastatic disease elsewhere. This was diagnosed and managed as enthesopathy. A Tc-MDP bone scan with SPECT/CT performed 9 months later confirmed an intensely osteoblastic mixed lytic/sclerotic metastasis at the left proximal tibia.
A 3-Question Symptom Assessment Score Can Predict Outcomes in Newly Diagnosed Multiple Myeloma (MM)
Authors: Bharat Nandakumar, Shaji K. Kumar, Prashant Kapoor, Francis K. Buadi, Martha Q. Lacy, Morie A. Gertz, Angela Dispenzieri, David Dingli, Yi L. Hwa, Amie Fonder, Miriam A. Hobbs, Suzanne R. Hayman, John A. Lust, Nelson Leung, Ronald S. Go, Yi Lin, Wilson I Gonsalves, Taxiarchis Kourelis, Mustaqeem A. Siddiqui, Robert A. Kyle, Carrie A. Thompson, S. Vincent Rajkumar, Rahma M Warsame
Journal: Blood (2020)
Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Peng Zhao, Ye-Jun Wu, Qing-Yuan Qu, Shan Chong, Xiao-Wan Sun, Rui-Xin Deng, Xiao Liu, Xiao-Lu Zhu, Wei Han, Yuan-Yuan Zhang, Feng-Rong Wang, Xiao-Dong Mo, Chen-Hua Yan, Jing-Zhi Wang, Yu Wang, Huan Chen, Yu-Hong Chen, Xiang-Yu Zhao, Ying-Jun Chang, Lan-Ping Xu, Kaiyan Liu, Xiao-Jun Huang, Xiao-Hui Zhang
Journal: Blood (2020)
Haploidentical Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with Myelofibrosis: A Multi-Institutional Experience
Authors: Siddharth Jayant Kunte, Lisa Rybicki, Auro Viswabandya, Asad Bashey, Madiha Iqbal, Michael R. Grunwald, Bhagirathbhai Dholaria, Hany Elmariah, Michael Ozga, Anurag K. Singh, Sameem Abedin, Vikas Gupta, Amy E. DeZern, Richard J. Jones, Aaron T. Gerds, Tania Jain
Journal: Blood (2020)
Safety and Longer-Term Efficacy of Concizumab Prophylaxis in Patients with Hemophilia a or b with Inhibitors: Results from the Extension Part of the Phase 2 explorer4 Trial
Authors: Amy D Shapiro, Giancarlo Castaman, Katarina Cepo, Sidsel Marie Tønder, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Guy Young, Silva Zupancic-Šalek, Victor Jimenez Yuste
Journal: Blood (2020)
Hypogammaglobulinemia and Infection Risk in Chronic Lymphocytic Leukemia (CLL) Patients Treated with CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cells
Authors: Natalie F. Uy, Edward Pequignot, Noelle V. Frey, Megan Davis, Elizabeth O. Hexner, Stephen J. Schuster, Saar Gill, Alison W. Loren, Stephan A Grupp, J. Joseph Melenhorst, Simon F Lacey, Joseph A Fraietta, Joan Gilmore, Lester Lledo, Wei-Ting Hwang, Don L. Siegel, Bruce L Levine, Carl H June, David L. Porter
Journal: Blood (2020)
A Multi-Omics Approach to X-Chromosome Inactivation (XCI) Identifies Severe Xci Skewing in Female Genetic Carriers of Hemophilia
Authors: Marsha M Wheeler, Kathryn Sheldon, Shelley N Fletcher, Angela Dove, Kerry W Lannert, Chris Frazar, Barbara A. Konkle, Deborah A Nickerson, Jill M Johnsen
Journal: Blood (2020)
MRI of the upper airways in children and young adults: the MUSIC study
Authors: Bernadette Elders, Pierluigi Ciet, Harm Tiddens, Wytse van den Bosch, Piotr Wielopolski, Bas Pullens
Journal: Thorax (2020)

Rationale Paediatric laryngotracheal stenosis (LTS) is often successfully corrected with open airway surgery. However, respiratory and vocal sequelae frequently remain. Clinical care and surgical interventions could be improved with better understanding of these sequelae. Objective The objective of this cross-sectional study was to develop an upper airway MRI protocol to obtain information on anatomical and functional sequelae post-LTS repair. Methods Forty-eight patients (age 14.4 (range 7.5–30.7) years) and 11 healthy volunteers (15.9 (8.2–28.8) years) were included. Spirometry and static and dynamic upper airway MRI (3.0 T, 30 min protocol) were conducted. Analysis included assessment of postoperative anatomy and airway lumen measurements during static and dynamic (inspiration and phonation) acquisitions. Main results Good image quality without artefacts was achieved for static and dynamic images in the majority of MRIs. MRI showed vocal cord thickening in 80.9% of patients and compared with volunteers, a significant decrease in vocal cord lumen area (22.0 (IQR 17.7–30.3) mm 2 vs 35.1 (21.2–54.7) mm 2 , p=0.03) but not cricoid lumen area (62.3±27.0 mm 2 vs 66.2±34.8 mm 2 , p=0.70). Furthermore, 53.2% of patients had an A-frame deformation at site of previous tracheal cannula, showing lumen collapse during inspiration. Dynamic imaging showed incomplete vocal cord abduction during inspiration in 42.6% and incomplete adduction during phonation in 61.7% of patients. Conclusions Static and dynamic MRI is an excellent modality to non-invasively image anatomy, tissue characteristics and vocal cord dynamics of the upper airways. MRI-derived knowledge on postsurgical LTS sequelae might be used to improve surgery.
Comparison of Reduced Intensity Conditioning - Allogeneic HCT and Autologous HCT for Elderly Patients with Acute Lymphoblastic Leukemia. an Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Authors: Sebastian Giebel, Myriam Labopin, Mohamed Houhou, Denis Caillot, Jürgen Finke, Didier Blaise, Nathalie Fegueux, Mark Edward Ethell, Jan J. Cornelissen, Edouard Forcade, Ibrahim Yakoub-Agha, Federico Lussana, Johan Maertens, Jean-Henri Bourhis, Pavel Jindra, Norbert Claude Gorin, Arnon Nagler, Mohamad Mohty
Journal: Blood (2020)
Abstract PO-047: Anti-proliferative effect of cannabidiol (CBD) against B and T-cell lymphoma
Authors: Saba Omer, Dawn Boothe, Mohammed Mansour, Muralikrishnan Dhanasekaran, Satyanarayana Pondugula
Journal: Cancer Research (2020)

Abstract In the last two decades, Cannabinoids have been studied extensively for its potential use in various fields of medicine including oncology. Today some of the cannabinoids are FDA approved for the treatment of chemotherapy-induced side effects in cancer treatment however, studies are showing their effect against tumor growth as well. Aggressive B cell lymphoma or Non-Hodgkin lymphoma (NHL) is the fifth leading cause of human cancer death and is the second fastest-growing cancer with regard to mortality in people as 30% of patients develop resistance against chemotherapy. For this reason, it is essential to develop novel strategies to improve the outcome of patients suffering from aggressive or therapy-resistant lymphoma. The purpose of this study was to demonstrate the antitumor effects of cannabinoids in B cell lymphoma using canine as a model due to striking similarities b/w canine and human B cell lymphoma in histology, biology and gene expression. For this study, Canine B cell lymphoma cell lines 1771 and CLBL1 were cultured in RPMI. Expression of cannabinoid receptors studied using qPCR. Based on receptor expression cells were treated with receptor agonists (AEA, 2AG, CBD, THC, WIN and HU-210,) and antagonists (S16 and S28). Cell viability assessed using MTT assay. Biochemical analysis performed using spectrofluorometry to evaluate apoptotic makers involved in inducing cell death. Data was analyzed using ordinary one way ANOVA on Prism software. All B cell lymphoma cell lines showed positive expression of CB1 and CB2 receptors. Cell viability assay demonstrated a dose-dependent decrease in cell proliferation with all cannabinoid receptor agonists used except for 2AG. Biochemical analysis showed a decrease in nitrite and caspase activity in treated cells as compared to control untreated cells. Our results suggest that cannabinoids have an anti-proliferative and apoptotic effect on canine lymphoma cells and it can be developed as a potential anti-cancer agent for the treatment of canine and human B cell lymphoma. Citation Format: Saba Omer, Dawn Boothe, Mohammed Mansour, Muralikrishnan Dhanasekaran, Satyanarayana Pondugula. Anti-proliferative effect of cannabidiol (CBD) against B and T-cell lymphoma [abstract]. In: Proceedings of the AACR Virtual Special Conference on Tumor Heterogeneity: From Single Cells to Clinical Impact; 2020 Sep 17-18. Philadelphia (PA): AACR; Cancer Res 2020;80(21 Suppl):Abstract nr PO-047.
Impact of Pathogenic Germ Line Variants in Adults with Acquired Bone Marrow Failure Syndromes <i>Vs</i>. Myeloid Neoplasia
Authors: Misam Zawit, Jibran Durrani, Wenyi Shen, Vera Adema, Cassandra M Kerr, Hassan Awada, Sunisa Kongkiatkamon, Carmelo Gurnari, Simona Pagliuca, Laila Terkawi, Bhumika J. Patel, Valeria Visconte, Hetty E. Carraway, Thomas LaFramboise, Seth J. Corey, Torsten Haferlach, Jaroslaw P. Maciejewski
Journal: Blood (2020)